Narcolepsy: current treatment options and future approaches

References

• AkimotoHHondaYTakahashiYPharmacotherapy in narcolepsyDis Nerv Syst19602113
   Google Scholar
• American Academy of Sleep MedicineInternational classification of sleep disordersDiagnostic and coding manual20052Westchester, IllinoisAmerican Academy of Sleep Medicine
   Google Scholar
• Arias-CarrionOMurillo-RodriguezEXuMTransplantation of hypocretin neurons into the pontine reticular formation:preliminary resultsSleep20042714657015683135
   PubMed Web of Science ®Google Scholar
• Arias-CarrionODrucker-ColinRMurillo-RodriguezESurvival rates through time of hypocretin grafted neurons within their projection siteNeurosci lett200640493716762505
   PubMed Web of Science ®Google Scholar
• BeerBStarkJKrieterPDOV 216,303, a ‘triple’ reuptake inhibitor: safety, tolerability, and pharmacokinetic profileJ Clin Pharmacol2004441360715545306
   PubMed Web of Science ®Google Scholar
• BeuersterienKMRogersAAEWalslebenJAHealth-related quality of life effects of modafinil for treatment of narcolepsySleep1999227576510505821
   PubMed Web of Science ®Google Scholar
• BilliardMBassettiCDauvilliersYEFNS guidelines on management of narcolepsyEur J Neurol20061310354816987156
   PubMed Web of Science ®Google Scholar
• BilliardMBessetAMontplaisirJModafinil: a double-blind multicenter studySleep199417Suppl10712
   Web of Science ®Google Scholar
• BilliardMNicoletADauvilliersYBassettiCBilliardMMignotEModafinil: the European experienceInforma Healthcare2007New YorkNarcolepsy and hypersomnia5619
   Google Scholar
• BlackJHoughtonWCSodium oxybate improves excessive daytime sleepiness in narcolepsySleep200629394616895262
   PubMed Web of Science ®Google Scholar
• BoeveBFSilberMHFermanTJMelatonin for treatment of REM sleep behavior disorder in neurological disorders:results in 14 patientsSleep Med20034281414592300
   PubMed Web of Science ®Google Scholar
• BrittonTHansenAHicksJGuidelines on the diagnosis and management of narcolepsy in adults and childrenEvidence-based guidelines for the UK with graded recommendations2002Ashtead, UKTaylor Patten Communications Ltd
   Google Scholar
• BroughtonRGhanemQHishikawaYLife effects of narcolepsy in 180 patients from North-America, Asia and Europe compared to matched controlsCan J Neurol Sci198182993047326610
   PubMed Web of Science ®Google Scholar
• BroughtonRJFlemingJAEGeorgeCFPRandomized, double-blind placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsyNeurology199749444519270575
   PubMed Web of Science ®Google Scholar
• BroughtonRMamelakMThe treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrateCan J Neurol Sci1979616264152
   PubMed Web of Science ®Google Scholar
• BroughtonRJMurrayBJBassettiCBilliardMMignotEThe behavioral management of narcolepsyNarcolepsy and hypersomnia2007New YorkInforma Healthcare497512
   Google Scholar
• ChemelliRMWillieJTSintonCMNarcolepsy in orexin knockout mice:molecular genetics of sleep regulationCell1999984375110481909
   PubMed Web of Science ®Google Scholar
• ChenWBlackJEinenMLate onset narcolepsy presenting as rapidly progressing muscle weaknes:response to plasmaphoresisAnn Neurol2005584899016130098
   PubMed Web of Science ®Google Scholar
• ChokrovertySSleep apnea in narcolepsySleep1986925033704450
   PubMed Web of Science ®Google Scholar
• DauvilliersYCarlanderBTouchonJSuccessful management of cataplexy with intravenous immunoglobulins at narcolepsy onsetAnn Neurol200456905815562415
   PubMed Web of Science ®Google Scholar
• DauvilliersYMontplaisirJMolinariNAge at onset of narcolepsy in two large populations of patients in France and QuebecNeurology20015720293311739821
   PubMed Web of Science ®Google Scholar
• FronczekROvereemSLammersGJAltered skin-temperature regulation in narcolepsy relates to sleep propensitySleep20062914444917162991
   PubMed Web of Science ®Google Scholar
• FronczekRRaymannRJEMRomeijnNManipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsySleep2008312334018274271
   PubMed Web of Science ®Google Scholar
• FronczekRVerschuurenJLammersGJResponse to intravenous immnoglobulin and placebo in a patient with narcolepsy with cataplexyJ Neurol20072541607817762946
   PubMed Web of Science ®Google Scholar
• GuilleminaultCAmphetamines and narcolepsy:use of the Stanford databaseSleep1993161992018506450
   PubMed Web of Science ®Google Scholar
• GuilleminaultCMancusoJQuera-SalvaMAViloxazine hydrochloride in narcolepsy:a preliminary reportSleep19869275793704453
   PubMed Web of Science ®Google Scholar
• HansonLRMartinezPMTaheriSIntranasal administration of hypocretin-1 (orexin A) bypasses the blood-brain barrier and targets the brain:a new strategy for the treatment of narcolepsyDrug Delivery Technol200446671
   Google Scholar
• HarshJRHaydukRRosenbergRThe efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsyCurr Med Res Opin2006227617416684437
   PubMed Web of Science ®Google Scholar
• HechtMLinLKushidaCAReport of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsySleep2003268091014655912
   PubMed Web of Science ®Google Scholar
• HublinCKaprioJPartinenMThe prevalence of narcolepsy:an epidemiological study of the Finnish Twin CohortAnn Neurol1994a35709168210228
   PubMed Web of Science ®Google Scholar
• HublinCPartinenMHeinonenESelegiline in the treatment of narcolepsyNeurology1994b4420951017969965
   PubMed Web of Science ®Google Scholar
• IijimaSSugitaYTshimaYTherapeutic effects of mazindol on narcolepsySleep1986926583704452
   PubMed Web of Science ®Google Scholar
• IvanenkoATaumanRGauzalDModafinil in the treatment of excessive daytime sleepiness in childrenSleep Med200345798214607353
   PubMed Web of Science ®Google Scholar
• KalesAVela-BuenoAKalesJDSleep disorders:sleep apnea and narcolepsyAnn Intern Med1987106434433544995
   PubMed Web of Science ®Google Scholar
• KeamSWalkerMCTherapies for narcolepsy with or without cataplexy:evidence based reviewCurr Opin Neurol20072069970317992092
   PubMed Web of Science ®Google Scholar
• KentJMSnaRIs, NaSSAs, and NARIs:new agents for the treatment of depressionLancet200035591118 Erratum in: Lancet, 355:200010752718
   PubMed Web of Science ®Google Scholar
• LangdonNShindlerJParkesJDFluoxetine in the treatment of cataplexySleep937133509809
   PubMed Web of Science ®Google Scholar
• LarrosaOde la LlaveYBarioSStimulant and anticataplectic effects of reboxetine in patients with narcolepsySleep200124282511322710
   PubMed Web of Science ®Google Scholar
• LecendreuxMMaretSBassettiCClinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boyJ Sleep Res200312347814633248
   PubMed Web of Science ®Google Scholar
• LinLFaracoJLiRThe sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 geneCell1999983657610458611
   PubMed Web of Science ®Google Scholar
• LinJSBrain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neuronsSleep Med Rev2000447150317210278
   PubMed Web of Science ®Google Scholar
• LinJSSakaiKVanni-MercierGInvolvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the catBrain Res1990523325302169324
   PubMed Web of Science ®Google Scholar
• MaitreMThe gamma-hydroxybutyrate signalling system in brain organisation and functional implicationsProg Neurobiol199751337619089792
   PubMed Web of Science ®Google Scholar
• MarelliSFantiniMBusekPAssociation between REM sleep behavior disorder and narcolepsy with and without cataplexySleep200629Abstract SupplA22930
   Google Scholar
• Martinez-RodriguezJIranzoASantamariaJStatus cataplecticus induced by abrupt withdrawal of clomipramineNeurologia200217113611864561
   PubMed Web of Science ®Google Scholar
• MayerGMeier-EwertKSelegiline hydrochloride treatment in narcolepsy. A double-blind, placebo-controlled studyClin Neuropharmacol199518306198665543
   PubMed Web of Science ®Google Scholar
• MayerGPeterHKesperKKomorbidität bei NarkolepsiepatientenDtsch Med Wochenschr200212719424612239653
   PubMed Web of Science ®Google Scholar
• MerritSLCohenFLSmithKMGoswamiMDepressive symptomatology in narcolepsyPsychosocial Aspects of Narcolepsy1992New YorkThe Haworth Press539
   Google Scholar
• MiedaMWillieJTHaraJOrexin peptides prevent cataplexy and improve wakefulness in an orexin-neuron-ablated model of narcolepsy in miceProc Natl Acad Sci USA200410146495415070772
   PubMed Web of Science ®Google Scholar
• MignotENishinoSGuilleminaultCModafinil binds to the dopamine uptake carrier site with low affinitySleep19941743677991954
   PubMed Web of Science ®Google Scholar
• MitlerMMAldrichMSKoobGFNarcolepsy and its treatment with stimulants (ASDA standards of practice)Sleep199417352717973321
   PubMed Web of Science ®Google Scholar
• MitlerMMShaforRHajdukovikRTreatment of narcolepsy:objective studies on methylphenidate, pemoline,and protriptylineSleep1986926043704451
   PubMed Web of Science ®Google Scholar
• MoldofskyHBroughtonRJHillJDA randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsySleep Med200011091610767651
   PubMed Web of Science ®Google Scholar
• MontplaisirJMichaudMDenesleRPeriodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairmentSleep Med20001163710767664
   PubMed Web of Science ®Google Scholar
• MorgenthalerTIKapurVKBrownTPractice parameters for the treatment of narcolepsy and other hypersomnias of central originSleep20073017051118246980
   PubMed Web of Science ®Google Scholar
• MuraliHKotagalSOff-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybateSleep2006291025916944670
   PubMed Web of Science ®Google Scholar
• NiederhoferHAtomoxetine also effective in patients suffering from narcolepsy?Sleep200528118916268387
   PubMed Web of Science ®Google Scholar
• NightingaleSOrgillJCEbrahimIOThe association between narcolepsy and REM behavior disorder (RBD)Sleep Med20056253815854856
   PubMed Web of Science ®Google Scholar
• NishinoSArrigoniJSheltonJEffects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsyJ Neurosci199717640189236248
   PubMed Web of Science ®Google Scholar
• NishinoSKanbayashiTSymptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin systemSleep Med Rev2005926931016006155
   PubMed Web of Science ®Google Scholar
• NishinoSMaoJSampathkumaranRIncreased dopaminergic transmission mediates the wake-promoting effects of CNS stimulantsSleep Res Online19981496111382857
   PubMedGoogle Scholar
• NishinoSMignotEPharmacological aspects of human and canine narcolepsyProgr Neurobiol1997522778
   PubMed Web of Science ®Google Scholar
• OhayonMMPriestRGZulleyJPrevalence of narcolepsy symptomatology and diagnosis in the European general populationNeurology20025818263312084885
   PubMed Web of Science ®Google Scholar
• PardiDBlackJGHB/sodium oxybate:neurobiology and impact on sleep and wakefulnessCNS Drugs200620993101817140279
   PubMed Web of Science ®Google Scholar
• ParkesJDDahlitzMAmphetamine prescriptionSleep19931620138506451
   PubMed Web of Science ®Google Scholar
• PeyronCFaracoJRogersWA mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsNat Med20006991710973318
   PubMed Web of Science ®Google Scholar
• PlazziGMontagnaPProviniFTreatment of narcolepsy with cataplexyLancet2007369108117398305
   PubMed Web of Science ®Google Scholar
• PrinzmetalMBloombergWThe use of benzedrine for treatment of narcolepsyJAMA193510520514
   Google Scholar
• RiehlJHondaKKwanMChronic oral administration of CG-3703, a thyrotropin-releasing hormone analog, increase wake and decreases cataplexy in canine narcolepsyNeuropsychopharmacology200023344510869884
   PubMed Web of Science ®Google Scholar
• RogersAEAldrichMSLinXComparison of three different sleep schedules for reducing daytime sleepiness in narcolepsySleep2001243859111403522
   PubMed Web of Science ®Google Scholar
• RoselaarSELangdonNLockCBSelegiline in the treatment of narcolepsySleep19871049153120270
   PubMed Web of Science ®Google Scholar
• SchachterMParkesJDFluvoxamine and clomipramine in the treatment of cataplexyJ Neurol Neurosurg Psychiatr19804317146766990
   PubMed Web of Science ®Google Scholar
• SchenckCHMahowaldMWMotor dyscontrol in narcolepsy:rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorderAnn Neurol1992323101642469
   PubMed Web of Science ®Google Scholar
• SchwartzJRNelsonMTSchwartzEREffects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepinessClin Neuropharmacol20042774915252267
   PubMed Web of Science ®Google Scholar
• ShibaTFujikiNWisorJWake promoting effects of thioperamide, a histamine H3 antagonist in orexin/ataxin-3 narcoleptic miceSleep200427Abstract SupplA2412
   Google Scholar
• ShindlerJSchachterMBrincatSAmphetamines, mazindol and fencamfamin in narcolepsyBMJ19852901167702859077
   PubMed Web of Science ®Google Scholar
• SilberMHBlackJLKrahnLEBassettiCBilliardMMignotEAutoimmune studies in narcolepsyNarcolepsy and hypersomnia2007New YorkInforma Healthcare4517
   Google Scholar
• SilberMHKrahnLEOlsonEJThe epidemiology of narcolepsy in Olmsted county, Minnesota:a population-based studySleep20022519720211902429
   PubMed Web of Science ®Google Scholar
• SmithMParkesJDDahlitzMVenlafaxine in the treatment of the narcoleptic syndromeJ Sleep Res19965Suppl 1217
   Google Scholar
• Standards of Practice CommitteePractice parameters for the treatment of narcolepsy:an update for 2000Sleep2001244516611403530
   PubMed Web of Science ®Google Scholar
• Standards of Practice Committee of the American Sleep Disorders AssociationPractice parameters for the use of stimulants in the treatment of narcolepsySleep199417348517973320
   PubMed Web of Science ®Google Scholar
• TatsumiMGroshanKBlakelyRDPharmacological profile of antidepressants and related compounds at human monoamine transportersEur J Pharmacol1997340249589537821
   PubMed Web of Science ®Google Scholar
• TedfordCEEdgarDMSeidelWFEffects of a novel, selective and potent histamine H3 receptor antagonist, GT-2332, on rat sleep/wakefulness and canine cataplexyAbstr Soc Neurosci1999251134
   Google Scholar
• ThannickalTCMooreRYNienhuisRReduced number of hypocretin neurons in human narcolepsyNeuron2000274697411055430
   PubMed Web of Science ®Google Scholar
• The Xyrem® International Study GroupA double-blind, placebo-controlled study demonstrates that sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsyJ Clin Sleep Med20051391717564408
   PubMed Web of Science ®Google Scholar
• ThorpyMJBlackJErmanMKThe safety profile of modafinil in disorders of sleep and wakefulnessNeurology200462Suppl 5A567
   Google Scholar
• ThorpyMJSnyderMAloesFSShort-term triazolam use improves nocturnal sleep of narcolepsticsSleep19921521261621021
   PubMed Web of Science ®Google Scholar
• US Modafinil in Narcolepsy Multicenter Study GroupRandomized trial of modafinil for the treatment of pathological somnolence in narcolepsyAnn Neurol19984388979450772
   PubMed Web of Science ®Google Scholar
• US Modafinil in Narcolepsy Multicenter Study GroupRandomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsyNeurology20005411667510720292
   PubMed Web of Science ®Google Scholar
• US Xyrem® Multicenter Study GroupA randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsySleep20022542911833860
   PubMed Web of Science ®Google Scholar
• US Xyrem® Multicenter Study GroupA 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsySleep20032631512627729
   PubMed Web of Science ®Google Scholar
• US Xyrem® Multicenter Study GroupSodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsySleep Med200451192315033130
   PubMed Web of Science ®Google Scholar
• Xyrem® International Study GroupFurther evidence supporting the use of sodium oxybate for the treatment of cataplexy:a double-blind, placebo-controlled study in 228 patientsSleep Med200564152116099718
   PubMed Web of Science ®Google Scholar
• WingYKLiRHLamCWThe prevalence of narcolepsy among Chinese in Hong-KongAnn Neurol2002515788412112103
   PubMed Web of Science ®Google Scholar
• WisorJPNishinoSSoraIDopaminergic role in stimulant induced wakefulnessJ Neurosci20012117879411222668
   PubMed Web of Science ®Google Scholar
• WyattRJFramDHBuchbinderRTreatment of intractable narcolepsy with a monoamine oxidase inhibitorN Engl J Med1971285987914328710
   PubMed Web of Science ®Google Scholar
• ZuberiSMMignotELingLVariable response to intravenous immunoglobulin therapy in childhood narcolepsyJ Sleep Res200413Suppl 1828
   Google Scholar